To Study Ocular Surface Morbidities among Glaucoma Patients on Anti-Glaucoma Drops

Downloads

Published

2023-07-07

Keywords:

.

Dimensions Badge

Issue

Vol. 9 No. 03 (2021): UP JOURNAL OF OPHTHALMOLOGY

Section

Original Study

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

© Author, Open Access. This article is licensed under a CC Attribution 4.0 License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/byncsa/4.0/.

Authors

  • Aditi Jhunjhunwala .
  • Ram Kumar Jaiswal .
  • Pooja Mishra .

Abstract

Title: To study ocular surface morbidities among glaucoma patients on anti-glaucoma drops.

Background: Glaucoma is a chronic, lifelong disease and it requires lifelong therapy as well. Topical anti-glaucoma drugs are often associated with symptoms and sign of toxicity.

How to Cite

1.
Jhunjhunwala A, Jaiswal RK, Mishra P. To Study Ocular Surface Morbidities among Glaucoma Patients on Anti-Glaucoma Drops . UPJO [Internet]. 2023 Jul. 7 [cited 2025 Feb. 23];9(03):36-9. Available from: https://upjo.org/index.php/upjo/article/view/504

Downloads

Download data is not yet available.